123 related articles for article (PubMed ID: 23453027)
1. Assessing the contribution of HRPT2 to the pathogenesis of jaw fibrous dysplasia, ossifying fibroma, and osteosarcoma.
de Mesquita Netto AC; Gomez RS; Diniz MG; Fonseca-Silva T; Campos K; De Marco L; Carlos R; Gomes CC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Mar; 115(3):359-67. PubMed ID: 23453027
[TBL] [Abstract][Full Text] [Related]
2. HRPT2 gene alterations in ossifying fibroma of the jaws.
Pimenta FJ; Gontijo Silveira LF; Tavares GC; Silva AC; Perdigão PF; Castro WH; Gomez MV; Teh BT; De Marco L; Gomez RS
Oral Oncol; 2006 Aug; 42(7):735-9. PubMed ID: 16458039
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
Parfitt J; Harris M; Wright JM; Kalamchi S
J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
[TBL] [Abstract][Full Text] [Related]
4. Evidence of molecular alterations in the tumour suppressor gene WWOX in benign and malignant bone related lesions of the jaws.
Diniz MG; Borges ER; Pimenta FJ; De Mesquita Netto AC; De Marco L; Gomez RS; Gomes CC
Oncol Rep; 2011 Feb; 25(2):499-502. PubMed ID: 21165567
[TBL] [Abstract][Full Text] [Related]
5. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
6. Identification of the first germline HRPT2 whole-gene deletion in a patient with primary hyperparathyroidism.
Domingues R; Tomaz RA; Martins C; Nunes C; Bugalho MJ; Cavaco BM
Clin Endocrinol (Oxf); 2012 Jan; 76(1):33-8. PubMed ID: 21790700
[TBL] [Abstract][Full Text] [Related]
7. GNAS mutational analysis in differentiating fibrous dysplasia and ossifying fibroma of the jaw.
Shi RR; Li XF; Zhang R; Chen Y; Li TJ
Mod Pathol; 2013 Aug; 26(8):1023-31. PubMed ID: 23503642
[TBL] [Abstract][Full Text] [Related]
8. Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene.
Zhao J; Yart A; Frigerio S; Perren A; Schraml P; Weisstanner C; Stallmach T; Krek W; Moch H
Oncogene; 2007 May; 26(23):3440-9. PubMed ID: 17130827
[TBL] [Abstract][Full Text] [Related]
9. Ossifying fibroma vs fibrous dysplasia of the jaw: molecular and immunological characterization.
Toyosawa S; Yuki M; Kishino M; Ogawa Y; Ueda T; Murakami S; Konishi E; Iida S; Kogo M; Komori T; Tomita Y
Mod Pathol; 2007 Mar; 20(3):389-96. PubMed ID: 17334331
[TBL] [Abstract][Full Text] [Related]
10. Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours.
Bradley KJ; Cavaco BM; Bowl MR; Harding B; Cranston T; Fratter C; Besser GM; Conceição Pereira M; Davie MW; Dudley N; Leite V; Sadler GP; Seller A; Thakker RV
Clin Endocrinol (Oxf); 2006 Mar; 64(3):299-306. PubMed ID: 16487440
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.
Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Maeng LS; Lee AH; Eun JW; Nam SW; Moon SD
Int J Oncol; 2014 Aug; 45(2):641-50. PubMed ID: 24889687
[TBL] [Abstract][Full Text] [Related]
12. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
Shattuck TM; Välimäki S; Obara T; Gaz RD; Clark OH; Shoback D; Wierman ME; Tojo K; Robbins CM; Carpten JD; Farnebo LO; Larsson C; Arnold A
N Engl J Med; 2003 Oct; 349(18):1722-9. PubMed ID: 14585940
[TBL] [Abstract][Full Text] [Related]
13. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
14. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.
Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
Clin Endocrinol (Oxf); 2014 Aug; 81(2):222-30. PubMed ID: 24716902
[TBL] [Abstract][Full Text] [Related]
15. HRPT2, a tumor suppressor gene for hyperparathyroidism-jaw tumor syndrome.
Wang PF; Tan MH; Zhang C; Morreau H; Teh BT
Horm Metab Res; 2005 Jun; 37(6):380-3. PubMed ID: 16001331
[TBL] [Abstract][Full Text] [Related]
16. Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation.
Aldred MJ; Talacko AA; Savarirayan R; Murdolo V; Mills AE; Radden BG; Alimov A; Villablanca A; Larsson C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):212-8. PubMed ID: 16448924
[TBL] [Abstract][Full Text] [Related]
17. A Novel Mutation in a Patient with Hyperparathyroidism-Jaw Tumour Syndrome.
Bellido V; Larrañaga I; Guimón M; Martinez-Conde R; Eguia A; Perez de Nanclares G; Castaño L; Gaztambide S
Endocr Pathol; 2016 Jun; 27(2):142-6. PubMed ID: 26995009
[TBL] [Abstract][Full Text] [Related]
18. Analysis of aberrantly spliced HRPT2 transcripts and the resulting proteins in HPT-JT syndrome.
Moon S; Kim JH; Shim JY; Ahn YB; Song KH; Cha BY; Maeng LS; Han JH
Mol Genet Metab; 2010 Aug; 100(4):365-71. PubMed ID: 20541447
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity.
Ciuffi S; Cianferotti L; Nesi G; Luzi E; Marini F; Giusti F; Zonefrati R; Gronchi G; Perigli G; Brandi ML
Endocr J; 2019 Apr; 66(4):319-327. PubMed ID: 30799315
[TBL] [Abstract][Full Text] [Related]
20. Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene.
Cavaco BM; Guerra L; Bradley KJ; Carvalho D; Harding B; Oliveira A; Santos MA; Sobrinho LG; Thakker RV; Leite V
J Clin Endocrinol Metab; 2004 Apr; 89(4):1747-52. PubMed ID: 15070940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
